Skip to main content
Michael Baine, MD, Radiation Oncology, Omaha, NE

Michael James Baine MD PhD

Urologic Cancer


Associate Professor and Medical Director

Join to View Full Profile
  • 505 S 45th StOmaha, NE 68198

  • Phone+1 402-559-5600

Dr. Baine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a member of the Department of Radiation Oncology at the University of Nebraska Medical Center, acting in a physician scientist role. My clinical practice is focused on GU malignancies with my lab investigating pancreas, prostate, and bladder cancers. I have specific interests in radiomics, ultrahypofractionated radiation treatment for prostate, body SBRT for oligometastatic diseases, and the interactions between high dose-per-fraction radiation treatments and the immune system with the hope of leveraging this into greater efficacy of immunotherapy.

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineResidency, Radiation Oncology, 2015 - 2019
  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 2014 - 2015
  • University of Nebraska College of Medicine
    University of Nebraska College of Medicine

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 2019 - 2026
  • NE State Medical License
    NE State Medical License 2019 - 2026
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Sigma Xi 2022
  • Alpha Sigma Nu Loyola Marymount University, 2006
  • Inductee Alpha Omega Alpha Honor Medical Society

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Impact of Neoadjuvant and Adjuvant Immunotherapy on the Survival of Pancreatic Cancer Patients: A Retrospective Analysis
    The Impact of Neoadjuvant and Adjuvant Immunotherapy on the Survival of Pancreatic Cancer Patients: A Retrospective AnalysisJune 9th, 2020
  • The Impact of Immunotherapy on the Survival of Pancreatic Adenocarcinoma Patients Who Received Definitive Surgery of the Pancreatic Tumor: A Retrospective Analysis of the National Cancer Database
    The Impact of Immunotherapy on the Survival of Pancreatic Adenocarcinoma Patients Who Received Definitive Surgery of the Pancreatic Tumor: A Retrospective Analysis of the National Cancer DatabaseJune 3rd, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: